These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 12642429)

  • 21. ADHD (ATTENTION DEFFICIT HYPERACTIVITY DISORDER)--A TROUBLING ENTITY, SOMETIMES PERPETUATING DURING ADULT LIFE.
    Amihăesei IC; Zamfir CL
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):10-4. PubMed ID: 27125066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attention-deficit hyperactivity disorder in adults.
    Wender PH
    Psychiatr Clin North Am; 1998 Dec; 21(4):761-74, v. PubMed ID: 9890120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnosis and medical treatment of ADHD in children and adolescents in primary care: a practical guide.
    Woodard R
    Pediatr Nurs; 2006; 32(4):363-70. PubMed ID: 16927730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Towards an integrative developmental model.
    Vance AL
    Aust N Z J Psychiatry; 2002 Aug; 36(4):485-7. PubMed ID: 12169146
    [No Abstract]   [Full Text] [Related]  

  • 26. Diagnosis and management of adult attention-deficit/hyperactivity disorder.
    Post RE; Kurlansik SL
    Am Fam Physician; 2012 May; 85(9):890-6. PubMed ID: 22612184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive-behavioral approaches to ADHD treatment in adulthood.
    Safren SA
    J Clin Psychiatry; 2006; 67 Suppl 8():46-50. PubMed ID: 16961430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology.
    Nutt DJ; Fone K; Asherson P; Bramble D; Hill P; Matthews K; Morris KA; Santosh P; Sonuga-Barke E; Taylor E; Weiss M; Young S;
    J Psychopharmacol; 2007 Jan; 21(1):10-41. PubMed ID: 17092962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement.
    Putukian M; Kreher JB; Coppel DB; Glazer JL; McKeag DB; White RD
    Clin J Sport Med; 2011 Sep; 21(5):392-401. PubMed ID: 21892014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
    Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
    Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DSM-5 further inflates attention deficit hyperactivity disorder.
    Batstra L; Frances A
    J Nerv Ment Dis; 2012 Jun; 200(6):486-8. PubMed ID: 22652611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current issues and trends in the diagnosis and treatment of adults with ADHD.
    Cumyn L; Kolar D; Keller A; Hechtman L
    Expert Rev Neurother; 2007 Oct; 7(10):1375-90. PubMed ID: 17939773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of placebo response in adults with attention-deficit/hyperactivity disorder: data from 2 randomized trials of osmotic-release oral system methylphenidate.
    Buitelaar JK; Sobanski E; Stieglitz RD; Dejonckheere J; Waechter S; Schäuble B
    J Clin Psychiatry; 2012 Aug; 73(8):1097-102. PubMed ID: 22780962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
    Rostain AL
    Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention-deficit/hyperactivity disorder.
    Selekman J
    J Sch Nurs; 2002 Oct; 18(5):270-6. PubMed ID: 12387593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
    Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
    Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.